11/13/2024
3:01 PM | 60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
Knight Therapeutics Inc (Filed by)
| Form SC 13G/A | |
11/06/2024
4:26 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
2:46 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form DEF 14A | |
10/08/2024
7:17 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
9:56 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form PRE 14A | |
09/30/2024
11:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
09/19/2024
3:30 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
|
09/11/2024
3:46 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
2:59 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
9:29 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
11:03 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
12:21 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/24/2024
4:05 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/22/2024
10:23 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/18/2024
11:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
07/16/2024
4:28 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
4:02 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/09/2024
2:37 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:06 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
4:26 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
1:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form DEF 14A | |
05/21/2024
7:22 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:23 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
TOOVEY STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:23 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:18 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Allen Charles W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:19 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:20 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
FIELD PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
10:56 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:19 PM | 60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
| Form SC 13G/A | |
04/03/2024
5:00 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
1:32 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/02/2024
2:31 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
2:33 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
11:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
01/22/2024
4:01 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
1:56 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
9:29 AM | 60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
| Form SC 13G | |
12/18/2023
8:23 AM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2023
11:41 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/15/2023
4:14 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form NT 10-Q | |
The next assassination attempt won’t be on Trump (Ad) President Trump is soon to be back in the White House.
Unity has been restored to the U.S.
But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person. I share with you in this special investigative documentary. |
